Health News
Date: May-24-2012
Factors influencing early life non-Hodgkin lymphoma (NHL) incidence include family characteristics, high fetal growth, older maternal age, low birth order, and male gender, according to a study published in the Journal of the National Cancer Institute. Over the last 50 years, NHL incidence increased substantially, although the overall incidence started to stabilize in the 1990s, at least among adults. But incidence has continued to climb in children, adolescents, and young adults. Perinatal factors have been thought to increase NHL risk, but previous studies of those factors were limited due...
Date: May-24-2012
Use of inhaled anticholinergics (IACs) has been associated with an increased risk of potentially dangerous heart arrhythmias among young asthma patients, according to a study conducted by researchers at the University of Illinois at Chicago. The medications are commonly used to help control asthma flare-ups, and recent studies have shown that they may be an effective treatment option for routine asthma management. The study was presented at the ATS 2012 International Conference in San Francisco. "In our study, we found that the use of IACs was associated with an increased risk of arrhythmias...
Date: May-24-2012
Children with pelvic and thigh fractures develop dangerous blood clots so rarely that anti-clotting therapy should be given only to those with underlying conditions that increase clotting risk, according to a study from Johns Hopkins Children's Center. The research, to be published in the June issue of the Journal of Pediatric Orthopaedics, challenges several earlier reports that found a relatively high risk of developing dangerous clots deep inside the veins among pediatric patients. The new findings, the investigators say, suggest that preemptive anti-coagulant medications may be best...
Date: May-24-2012
A University of Michigan Health System study provides new clues about the health-damaging molecular changes set in motion by eating high-fat foods. A better understanding of the body's response to indulgent eating could lead to new approaches for treating diabetes and metabolic syndrome. High fat foods can contribute to obesity, which increases the risk for developing type 2 diabetes. The researchers learned a key protein called Bcl10 is needed for the free fatty acids, which are found in high-fat food and stored in body fat, to impair insulin action and lead to abnormally high blood sugar. In...
Date: May-24-2012
A team of University of Hawaii Cancer Center scientists led by James Turkson, Ph.D. have created a new type of anti-cancer drug named BP-1-102. The drug, which can be orally administered, targets a key protein that triggers the development of many types of cancer including lung, breast and skin cancers. The development of BP-1-102 was guided by the research teams computer based molecular analysis of the cancer causing Stat 3 protein that causes cancer by promoting abnormal cell growth in otherwise healthy cells. "The molecular structure of the hyperactive Stat3 protein basically resembles two...
Date: May-24-2012
Johns Hopkins scientists have discovered a protein that appears to play an important regulatory role in deciding whether stem cells differentiate into the cells that make up the brain, as well as countless other tissues. This finding, published in Developmental Cell, could eventually shed light on developmental disorders as well as a variety of conditions that involve the generation of new neurons into adulthood, including depression, stroke, and posttraumatic stress disorder. Researchers have long known that a small group of proteins called Notch plays a pivotal role in helping the immature...
Date: May-24-2012
Researchers from the University of Minnesota and Washington University in St. Louis have found folic acid fortification of grain products in the United States may have an impact on lowering some childhood cancers. The new research, published online in the journal Pediatrics, shows fortification does not appear to be causing childhood cancer rates to increase, and also finds a notable decrease in two types of childhood cancer. This study was led by Amy Linabery, Ph.D., postdoctoral fellow in the University of Minnesota's Division of Pediatric Epidemiology and Clinical Research, and Kimberly...
Date: May-24-2012
Researchers at Trinity College Dublin have reported the results of groundbreaking research into the prevention of cerebral oedema or swelling of the brain, a major cause of death in people who have sustained a traumatic injury to the brain, out of hospital cardiac arrest or stroke. The research, which is published this week in the international journal, Nature Communications, uses a radically new patented technology, developed in Ireland and termed, 'Neuronal Barrier Modulation' which has been shown in an animal model simulating human brain swelling, to be highly effective in reducing the...
Date: May-24-2012
Pathological Aging Brains Contain The Same Amyloid Plaques As Alzheimer's Disease Main Category: Alzheimer's / Dementia Article Date: 24 May 2012 - 0:00 PDT email to a friend printer friendly opinions rate article Current ratings for: 'Pathological Aging Brains Contain The Same Amyloid Plaques As Alzheimer's Disease' Patient / Public: Healthcare Prof: Pathological aging (PA) is used to describe the brains of people which have Alzheimer's disease (AD)-like pathology but where the person showed no signs of cognitive impairment whilst they were alive. New research,...
Date: May-24-2012
A novel pancreatic cancer vaccine shows promise in improving survival when added to standard treatment, according to new research out of University Hospitals Case Medical Center's Seidman Cancer Center and Case Western Reserve University School of Medicine. The Phase 2 data was presented at the Annual Meeting of the Society for Surgery of the Alimentary Tract, part of Digestive Disease Week in San Diego. In the plenary session titled "Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: a Phase 2 Study" (PT Abstract # 028), Jeffrey Hardacre, MD, lead...